Delayed Chylothorax After Endometrial Carcinoma: A Case of Confirmed Thoracic Duct Leak Successfully Managed Conservatively Cureus
The ascent of novel alternative methods in drug development spotlights the dual needs for improved biological fidelity to in vivo, along with reproducibility, especially in regulatory applications. The need for …
Endometriosis (EMS) is a chronic inflammatory disorder affecting ~10% of reproductive-age women, with increasing evidence implicating the microbiome in its pathogenesis through immunomodulation and estrogen metabolism. This study investigated microbiome …
Current models of endometriosis (EMs) still have limitations in replicating the key pathological features of human EMs, particularly the cyclic bleeding associated with ectopic lesions. To address this gap, this …
Intravascular adenomyomatosis (IA), characterised by endometrial-type glands or stroma embedded within smooth muscle tissue inside myometrial vessels, is a rare variant within the spectrum of uterine intravenous leiomyomatosis (IVL).
Managing Progression After Immunotherapy in Endometrial Cancer OncLive
New Endometrial Targets Beyond HER2 OncLive
Navigating Institutional Barriers: Inventory Management and EHR Pathways in Endometrial Cancer Pharmacy Times
Therapeutic Sequencing and NCCN Guidelines in Endometrial Cancer Pharmacy Times
Adenomyosis Independently Increases Risk for Endometrial Proliferative Disorders Oncology Nurse Advisor